Velocity Vlog: Advances in Merkel Cell Carcinoma - Therapeutic Advances and the Path Forward

Submitted by onc_editor on Fri, 01/26/2018 - 16:42

Velocity Vlog: Advances in Merkel Cell Carcinoma - Therapeutic Advances and the Path Forward

 

Recently completed and ongoing clinical trials indicate that Merkel Cell Carcinoma (MCC) is amenable to immunotherapy, and an immune checkpoint inhibitor recently received FDA approval for its treatment. This activity features Dr. Paul Nghiem sharing emerging data and expert analysis about diagnosis, the emergence of immunotherapy as a viable therapeutic option, and the evolving standard of care for MCC.